✦ LIBER ✦

A phase I/II study using oral topotecan (OT) with intravenous paclitaxel (P) as first-line therapy for patients (pts) with advanced non-small cell lung cancer (NSCLC)

✍ Scribed by Eckardt, J.R; Fanucchi, M.P; Stewart, D.J; Beckman, R.A; Dobbs, T.W; Wilson, J.J; Ho, M.L; Fields, S.Z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I/II study using oral topotecan

✍ Eckardt, J.R; Fanucchi, M.P; Stewart, D.J; Beckman, R.A; Dobbs, T.W; Wilson, J.J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 121 KB

Single agent oral topotecan (OT) as firs

✍ Eckardt, J.R; Palmer, M.C; Fanucchi, M.P; Gralla, R; Martins, H; Poulin, R; Fiel 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB

A phase II study of carboplatin and pacl

✍ Giorgio, Carmelo Giannitto; Pappalardo, Alessandro; Russo, Antonio; Giuffrida, D 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Second-line (SL) weekly paclitaxel (P) i

✍ Socinski, M.A; Kies, M; Unger, P; Peterman, A; Gillenwater, H.H; Schell, M; Bakr 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 231 KB

Phase II study of weekly paclitaxel as s

✍ Ceresoli, Giovanni Luca; Gregorc, Vanesa; Cordio, Stefano; Bencardino, Katia Bru 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 117 KB

P-204 Mature results of a non-platinum-b

✍ Wozniak, Antoinette J. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 388 KB